Skip to main content

Table 1 ICU basic characteristics (n = 140)

From: Prognostic factors for advanced lung cancer patients with do-not-intubate order in intensive care unit: a retrospective study

 

All patients (n = 140)

28 days Survivors (n = 44)

28 days Non-survivors (n = 96)

p Value

Age (Median, range)

73 (44–99)

74 (47–99)

72 (44–93)

0.054

BMI (Median, range)

21 (13–33)

21 (13–32)

21 (15–33)

0.971

Sex

 Male

87 (62.1)

29 (65.9)

58 (60.4)

0.578

 Female

53 (37.9)

15 (34.1)

38 (39.6)

 

Smoking history

 Ever smoker

76 (54.3)

24 (54.5)

52 (54.2)

1.00

 Never smoker

64 (45.7)

20 (45.5)

44 (45.8)

 

ECOG

 0–1

62 (44.3)

15 (34.1)

47 (49.0)

0.142

 >  = 2

78 (55.7)

29 (65.9)

49 (51.0)

 

Driver mutation

60 (42.9)

20 (45.5)

40 (41.7)

0.715

Treatment lines

2 (0–10)

1 (0–8)

2 (0–10)

0.142

APACHEII (Median, SE)

14 (± 0.66)

12 (± 0.98)

15 (± 0.83)

0.019

NIPPVa

137 (97.9)

43 (97.7)

94 (97.9)

1.000

Recent anticancer treatment

 Nilb

52 (37.1)

18 (40.9)

34 (35.4)

0.110

 Chemotherapy

38 (27.1)

8 (18.2)

30 (31.3)

 

 Target therapy

37 (26.4)

16 (36.4)

21 (21.9)

 

 Radiotherapy

13 (9.3)

2 (4.5)

11 (11.5)

 

GCS

14 (3–15)

15 (3–15)

14 (3–15)

0.172

PaO2/FiO2 (Mean, SD)

174.2 ± 104

209.6 ± 111.4

157.9 ± 96.7

0.006

PaCO2

42.5 ± 16.4

41.3 ± 13.8

43.1 ± 17.5

0.542

pH

7.40 ± 0.11

7.41 ± 0.11

7.40 ± 0.01

0.430

Lactate

28.8 ± 24.5

26.2 ± 29

30 ± 22.5

0.499

Neutropenia

7 (5)

1 (2.3)

6 (6.3)

0.433

Reasons of ICU admission

 Sepsis/infection

73 (52.1)

21 (47.7)

52 (54.2)

0.553

 Cancer related

40 (28.6)

13 (29.5)

27 (28.1)

 

 Treatment related

15 (10.7)

7 (15.9)

8 (8.3)

 

 Underlying disease

12 (8.6)

3 (6.8)

9 (9.4)

 
  1. aThree patients did not use NIPPV: one infection, one liver failure due to cancer progression, and one IICP due to tumor
  2. b”Nil” represents patients who did not receive any anticancer treatment 30 days prior to ICU admission